X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
index medicus (25) 25
oncology (19) 19
female (16) 16
male (16) 16
cancer (14) 14
human papillomavirus (10) 10
middle aged (9) 9
papillomavirus infections (9) 9
patients (9) 9
care and treatment (8) 8
neck-cancer (8) 8
radiotherapy (8) 8
oropharyngeal neoplasms - virology (7) 7
research (7) 7
squamous cell carcinoma (7) 7
surgery (7) 7
aged (6) 6
cancer therapies (6) 6
cervical cancer (6) 6
head (6) 6
hpv (6) 6
medical research (6) 6
oropharyngeal cancer (6) 6
papillomaviruses (6) 6
prevalence (6) 6
radiology, nuclear medicine & medical imaging (6) 6
squamous-cell carcinoma (6) 6
adult (5) 5
cancer research (5) 5
chemotherapy (5) 5
head and neck cancer (5) 5
otorhinolaryngology (5) 5
prognosis (5) 5
quality of life (5) 5
radiation therapy (5) 5
risk factors (5) 5
head & neck cancer (4) 4
health aspects (4) 4
hospitals (4) 4
immunology (4) 4
locally advanced head (4) 4
medicine, general & internal (4) 4
papillomavirus infections - complications (4) 4
papillomavirus infections - virology (4) 4
studies (4) 4
survival (4) 4
throat cancer (4) 4
toxicity (4) 4
tumors (4) 4
united kingdom (4) 4
abridged index medicus (3) 3
adjuvant treatment (3) 3
aged, 80 and over (3) 3
analysis (3) 3
carcinoma, squamous cell - virology (3) 3
clinical trials (3) 3
complications and side effects (3) 3
epidemiology (3) 3
genetics (3) 3
head and neck neoplasms - pathology (3) 3
hematology, oncology and palliative medicine (3) 3
history (3) 3
human-papillomavirus (3) 3
medicine & public health (3) 3
mortality (3) 3
oncogene proteins, viral - immunology (3) 3
oncology, experimental (3) 3
oropharyngeal neoplasms - epidemiology (3) 3
prospective studies (3) 3
radiation (3) 3
radiation-therapy (3) 3
t-lymphocytes, cytotoxic - immunology (3) 3
tumor burden (3) 3
women (3) 3
womens health (3) 3
1506 (2) 2
1684 (2) 2
1717 (2) 2
1733 (2) 2
antigen presentation (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antitumor immunity (2) 2
biography (2) 2
carcinoma (2) 2
carcinoma, squamous cell - radiotherapy (2) 2
carcinoma, squamous cell - surgery (2) 2
carcinoma, squamous cell - therapy (2) 2
clinical target volume (2) 2
communication (2) 2
criteria (2) 2
cytotoxic t-lymphocytes (2) 2
delineation (2) 2
dendritic cells (2) 2
deoxyribonucleic acid--dna (2) 2
diagnosis (2) 2
disease-free survival (2) 2
dk/atira/pure/researchoutput/pubmedpublicationtype/d013485 (2) 2
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (2) 2
dysphagia (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 97, Issue 5, pp. 892 - 893
Journal Article
Head & Neck, ISSN 1043-3074, 01/2016, Volume 38, Issue 1, pp. 157 - 157
Journal Article
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10166, pp. 51 - 60
Journal Article
Journal Article
by Cohen, Ezra E W and Cohen, Ezra and Soulières, Denis and Le Tourneau, Christophe and Dinis, Jose and Dinis, José and Licitra, Lisa and Ahn, Myung-Ju and Soria, Ainara and Machiels, Jean-Pascal and Mach, Nicolas and Mehra, Ranee and Burtness, Barbara Ann and Burtness, Barbara and Zhang, Pingye and Cheng, Jonathan and Swaby, Ramona F and Harrington, Kevin and Harrington, Kevin J and Acosta-Rivera, Mirelis and Adkins, Douglas R and Aghmesheh, Morteza and Airoldi, Mario and Aleknavicius, Eduardas and Al-Farhat, Yousuf and Algazi, Alain P and Almokadem, Salah and Alyasova, Anna and Bauman, Jessica R and Benasso, Marco and Berrocal, Alfonso and Bray, Victoria and Caponigro, Francesco and Castro, Ana and Cescon, Terrence P and Chan, Kelvin and Chaudhry, Arvind and Chauffert, Bruno and Csoszi, Tibor and De Boer, J.P and Delord, Jean-Pierre and Dietz, Andreas and Dupuis, Charlotte and Digue, Laurence and Erfan, Jozsef and Escobar Alvarez, Yolanda and Evans, Mererid and Fidler, Mary Jo and Forster, Martin David and Friesland, Signe and Ganti, Apar K and Geoffrois, Lionnel and Grant, Cliona and Gruenwald, Viktor and Hoffmann, Thomas and Horvai, Geza and Inciura, Arturas and Jang, Raymond and Jankowska, Petra and Jimeno, Antonio and Joseph, Mano and Juarez Ramiro, Alejandro and Karaszewska, Boguslawa and Kawecki, Andrzej and Keilholz, Ulrich and Keller, Ulrich and Kim, Sung-Bae and Kocsis, Judit and Kotecki, Nuria and Kozloff, Mark F and Lambea, Julio and Landherr, Laszlo and Lantsukhay, Yuri and Lazarev, Sergey Alexandrovich and Lee, Lip Way and Lifirenko, Igor Dmitrievich and Martincic, Danko and Matorin, Oleg Vladmirovhich and McGrath, Margaret and Misiukiewicz, Krzysztof and Morris, John C and Mufazalov, Fagim Fanisovich and Niu, Jiaxin and Pamoorthy Srinivasan, Devraj and Perez Segura, Pedro and Rauch, Daniel and Ribeiro, Maria Leonor and Rodriguez, Cristina and Rolland, Frederic and Russo, Antonio and Ruzsa, Agnes and Sanches, Frederico and Shin, Sang-Won and Shtiveland, Mikhail and Soulieres, Denis and Specenier, Pol and Szekanecz, Eva and Szota, Judit and van Herpen, Carla M.L and Velez-Cortes, Hector A and ... and Keynote-040 Investigators and KEYNOTE-040 investigators
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 156 - 167
There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour... 
CRITERIA | TRIAL | MEDICINE, GENERAL & INTERNAL | NIVOLUMAB | CANCER | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Docetaxel - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Cetuximab - therapeutic use | Cetuximab - adverse effects | Docetaxel - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Squamous Cell Carcinoma of Head and Neck - drug therapy | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Disease Progression | Head and Neck Neoplasms - pathology | Methotrexate - adverse effects | Squamous Cell Carcinoma of Head and Neck - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cetuximab - administration & dosage | Methotrexate - administration & dosage | Aged | Methotrexate | Squamous cell carcinoma | Metastasis | Therapy | Toxicity | Perforation | Clinical trials | Oncology | Cancer therapies | Metastases | Skin cancer | Anticancer properties | Pembrolizumab | Randomization | Motivation | Platinum | Neck | Safety | Medical treatment | Fatigue | Hypothyroidism | Survival | Patients | Chemotherapy | Interactive systems | Large intestine | Head and neck cancer | Ligands | Tumors
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 10/2019, Volume 9
PATHOS is a phase II/III randomized controlled trial (RCT) of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery... 
Papillomaviruses | Care and treatment | Squamous cell carcinoma | Prognosis | Oncology, Experimental | Adjuvant treatment | Research | Papillomavirus infections | Cancer | HPV-related head and neck squamous cell carcinoma | transoral surgery | deintensification | adjuvant | PATHOS
Journal Article
Physics in Medicine and Biology, ISSN 0031-9155, 06/2016, Volume 61, Issue 13, pp. 4855 - 4869
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2013, Volume 13, Issue 1, pp. 220 - 220
Journal Article
Journal Article